Brette L. Trost
Lawyers
Filters
Gracell Biotechnologies $209 million IPO and Nasdaq listing
We advised the underwriters on the IPO of ADSs
Jamf Holding $352 million follow-on offering
Davis Polk advised the representatives of the several underwriters in connection with the $352 million follow-on offering of 11,000,000 shares of common stock of Jamf Holding Corp. sold by…
Biodesix $72 million IPO
Davis Polk advised the joint book-running managers and representatives of the several underwriters on the $72 million initial public offering by Biodesix, Inc. The common stock is listed on…
MediaAlpha $175.8 million IPO
Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the $175.8 million initial public offering of 10,637,500 shares of Class A…
Aligos Therapeutics $150 million IPO
Davis Polk advised the representatives of the several underwriters in connection with the $150 million initial public offering of 10,000,000 shares of common stock of Aligos…
Array Technologies $1.2 billion IPO
Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the $1.2 billion initial public offering of 54,625,000 shares of common…
Aziyo Biologics $50 million IPO
Davis Polk advised the representatives of the several underwriters in connection with the $50 million initial public offering of common stock by Aziyo Biologics, Inc. The common stock…
Gilead Sciences $7.25 billion senior notes offering
Davis Polk advised Gilead Sciences, Inc. in connection with an SEC-registered offering of $7.25 billion aggregate principal amount of senior notes, consisting of (i) $500 million aggregate…
Jamf Holding $538.2 million IPO
Davis Polk advised the representatives of the several underwriters in connection with the $538.2 million initial public offering of 20,700,000 shares of common stock of Jamf Holding Corp.,…